The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre
- 1 January 1995
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 71 (1), 140-145
- https://doi.org/10.1038/bjc.1995.29
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Consensus review of the clinical utility of dna cytometry in carcinoma of the breastCytometry, 1993
- DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancerInternational Journal of Cancer, 1992
- Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?European Journal Of Cancer, 1992
- Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Node negative breast cancer.BMJ, 1990
- A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysisCytometry, 1990
- Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumorsCytometry, 1990
- Measurement of S‐phase fractions in lymphoid tissue comparing fresh versus paraffin‐embedded tissue and 4′,6′ ‐diamidino‐2 phenylindole dihydrochloride versus propidium iodide stainingCytometry, 1989
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCERThe Lancet, 1983